logo
...
...

Essentials of Antimicrobial Stewardship

ISBN: 978936616518920252/e

Key Features

  • 1000 plus corrections/updates are added with complete revision/correction of 300 plus tables in the book.
  • Major revision in interpretation of AST Chapter as per latest guidelines from CLSI and EUCAST incorporating several updates such as
    • Tier system of CLSI, update in the list of SDD and ECV
    • Update in the clinical breakpoints including Salmonella/Shigella breakpoint table
    • Update in the reporting of fosfomycin, aminoglycosides, CZA-ATM synergy
    • Update on AST reporting of B. cepacia, B. pseudomallei, Stenotrophomonas, A. baumannii
    • Update on treatment recommendations for invasive enterococcal infections
  • Updates on Treatment guidelines and Dosing Regimens.
  • New Duke's criteria 2023 for IE.
  • Major update: A new Module on ‘Decision to be taken on VITEK-AES modifications’.
  • Major update: A new Practical Module in Validation of Antibiogram based on general acceptable S% rules (with new exercise).
  • Major update: Practical Module on Pathogen-directed (PD) AMS audit.
  • Updates in list of drugs in AWaRe classification.
    • Revised definitions on antimicrobial consumption (AMC) and antimicrobial use (AMU)
    • Major updates on— fosfomycin and CZA-ATM synergy testing methods, AmpC detection methods etc.
  • Major updates on BMQ and MIC guiding tables and selective reporting.
  • >40 newer antimicrobials have been incorporated in every chapter of Antimicrobial Section such as newer β-lactams and BLBLI, newer aminoglycosides, newer tetracyclines, newer quinolones and several novel antimicrobials.
  • A major revision has been carried on treatment of tuberculosis chapter.
  • Major revision on chapters on ‘Targeted therapy for GNB and GPC’.
MRP
TBA
Inclusive of all taxes

    Key Features

    • 1000 plus corrections/updates are added with complete revision/correction of 300 plus tables in the book.
    • Major revision in interpretation of AST Chapter as per latest guidelines from CLSI and EUCAST incorporating several updates such as
      • Tier system of CLSI, update in the list of SDD and ECV
      • Update in the clinical breakpoints including Salmonella/Shigella breakpoint table
      • Update in the reporting of fosfomycin, aminoglycosides, CZA-ATM synergy
      • Update on AST reporting of B. cepacia, B. pseudomallei, Stenotrophomonas, A. baumannii
      • Update on treatment recommendations for invasive enterococcal infections
    • Updates on Treatment guidelines and Dosing Regimens.
    • New Duke's criteria 2023 for IE.
    • Major update: A new Module on ‘Decision to be taken on VITEK-AES modifications’.
    • Major update: A new Practical Module in Validation of Antibiogram based on general acceptable S% rules (with new exercise).
    • Major update: Practical Module on Pathogen-directed (PD) AMS audit.
    • Updates in list of drugs in AWaRe classification.
      • Revised definitions on antimicrobial consumption (AMC) and antimicrobial use (AMU)
      • Major updates on— fosfomycin and CZA-ATM synergy testing methods, AmpC detection methods etc.
    • Major updates on BMQ and MIC guiding tables and selective reporting.
    • >40 newer antimicrobials have been incorporated in every chapter of Antimicrobial Section such as newer β-lactams and BLBLI, newer aminoglycosides, newer tetracyclines, newer quinolones and several novel antimicrobials.
    • A major revision has been carried on treatment of tuberculosis chapter.
    • Major revision on chapters on ‘Targeted therapy for GNB and GPC’.
    MRP
    TBA
    Inclusive of all taxes

      Description

      This second edition is launched with humongous updates on topics added/revised such as:
      - 2023 to 2025 CLSI/EUCAST updates (500 plus corrections/updates are added with complete update on 75 plus tables in these chapters)
      - Newer Antimicrobials - 42 new antibiotics are discussed new in this new edition
      - Updates on Treatment guidelines and  Dosing Regimens
      - New Duke's criteria 2023
      - Module on interpretation for AES modification of VITEK AST
      - Practical Module in Validation of Antibiogram
      - Practical Module on Pathogen directed AMS audit

      Permissions

      Request permissionto reuse content from this site

      Product Details

      Publisher :

      JPB

      Edition :

      2/e

      Binding :

      Hard Back

      Language :

      English

      Pages :

      952

      ISBN-13 :

      9789366165189

      Item Weight :

      2400 grams

      Dimensions :

      8.5 x 11

      Printing Format Color :

      Four Color

      Copyright year :

      2025